Arquiza, Shattriea M.
HRN: 14-56-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CEFTRIAXONE 1G (VIAL)
05/11/2022
05/17/2022
IV DRIP
1.3 G
OD
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes